Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
260%
upside
5 price targets
|
0
%
|
|
|
|
258%
upside
4 price targets
|
0
%
|
|
|
|
252%
upside
3 price targets
|
0
%
|
|
|
29
C4 Therapeutics
CCCC
$228M
|
247%
upside
4 price targets
|
0
%
|
|
|
246%
upside
3 price targets
|
0
%
|
|
|
|
238%
upside
4 price targets
|
0
%
|
|
|
|
237%
upside
3 price targets
|
0
%
|
|
|
|
235%
upside
4 price targets
|
0
%
|
|
|
|
218%
upside
5 price targets
|
0
%
|
|
|
|
214%
upside
3 price targets
|
0
%
|
|
|
36
Sagimet Biosciences
SGMT
$297M
|
212%
upside
4 price targets
|
0
%
|
|
|
211%
upside
3 price targets
|
0
%
|
|
|
|
199%
upside
3 price targets
|
0
%
|
|
|
|
199%
upside
5 price targets
|
0
%
|
|
|
|
195%
upside
3 price targets
|
0
%
|
|
|
|
195%
upside
5 price targets
|
0
%
|
|
|
|
194%
upside
3 price targets
|
0
%
|
|
|
|
193%
upside
4 price targets
|
0
%
|
|
|
|
190%
upside
3 price targets
|
0
%
|
|
|
|
188%
upside
3 price targets
|
0
%
|
|
|
|
184%
upside
3 price targets
|
0
%
|
|
|
|
184%
upside
9 price targets
|
0
%
|
|
|
|
183%
upside
3 price targets
|
0
%
|
|
|
|
183%
upside
5 price targets
|
0
%
|
|
|
|
182%
upside
3 price targets
|
0
%
|
|